Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Payables (2020 - 2025)

Historic Payables for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $50.3 million.

  • GeneDx Holdings' Payables fell 1078.06% to $50.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.3 million, marking a year-over-year decrease of 1078.06%. This contributed to the annual value of $31.0 million for FY2024, which is 1728.16% down from last year.
  • As of Q3 2025, GeneDx Holdings' Payables stood at $50.3 million, which was down 1078.06% from $49.2 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Payables high stood at $115.9 million for Q2 2022, and its period low was $31.0 million during Q4 2024.
  • In the last 5 years, GeneDx Holdings' Payables had a median value of $49.2 million in 2025 and averaged $55.1 million.
  • As far as peak fluctuations go, GeneDx Holdings' Payables soared by 22381585.26% in 2021, and later crashed by 5587.08% in 2023.
  • Quarter analysis of 5 years shows GeneDx Holdings' Payables stood at $44.7 million in 2021, then skyrocketed by 89.91% to $84.9 million in 2022, then plummeted by 55.87% to $37.5 million in 2023, then fell by 17.28% to $31.0 million in 2024, then skyrocketed by 62.46% to $50.3 million in 2025.
  • Its last three reported values are $50.3 million in Q3 2025, $49.2 million for Q2 2025, and $41.9 million during Q1 2025.